<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02219308</url>
  </required_header>
  <id_info>
    <org_study_id>141025</org_study_id>
    <nct_id>NCT02219308</nct_id>
  </id_info>
  <brief_title>Pain Control for Intrauterine Device Placement Using Paracervical Block</brief_title>
  <official_title>Pain Control for Intrauterine Device Placement: A Randomized Controlled Trial of Paracervical Block</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, San Diego</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, San Diego</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Intrauterine device (IUD) placement can be painful for patients during and after the
      procedure. Fear of pain from IUD insertion can be a barrier to obtaining this highly
      effective long acting reversible contraception. Currently there are no proven effective
      methods for reduction of pain during and after placement of modern IUDs. Paracervical block
      pain may decrease this placement pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Modern IUDs are highly effective long acting reversible forms of contraception. The Mirena
      IUD is 99.8% effective and the Paragard copper IUD is 99.2% effective in preventing
      pregnancy. Fear of IUD placement can be a barrier to obtaining this highly effective form of
      birth control. The current standard of care for pain management during and after IUD
      placement is no medication, as randomized control trials published to date have limited data
      regarding use of medications to decrease pain. There has been one trial to suggest that the
      use of naproxen with 1% lidocaine paracervical block (PCB) compared to PCB alone may decrease
      pain after IUD placement in primarily nulliparous patients. However, this study was with the
      much wider and no longer available Dalkon Shield IUD. In addition, this study did not show
      any significant decrease in pain scores during IUD placement. Studies to evaluate
      effectiveness of ibuprofen and misoprostol have shown no significant decrease in pain scores
      during and after IUD insertion, although the majority of participants in these studies were
      multiparous. There is some suggestion that 2% lidocaine gel one minute prior to IUD insertion
      may have some decrease in pain, although this study was poorly designed.

      Although there is no standard of care in regards to pain medication administration prior to
      IUD placement, providers often suggest paracervical prior IUD insertion among nulliparous
      women. Therefore the primary aim of this study is to determine whether a paracervical block
      (PCB) decreases pain associated with intrauterine device (IUD) placement compared to no
      parcervical block. We hypothesize that administration of a PCB of 20 mL 1% buffered lidocaine
      prior to IUD placement will decrease pain scores by at least 20mm on a visual analog scale at
      various time points during IUD placement when compared to no paracervical block.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 2014</start_date>
  <completion_date type="Actual">October 2017</completion_date>
  <primary_completion_date type="Actual">October 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Pain with Intrauterine Device (IUD) Placement</measure>
    <time_frame>1 year</time_frame>
    <description>Distance (mm) from the left of the 100-mm VAS scale (reflecting magnitude of pain) recorded at time of IUD Placement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Baseline and Reported Pain at different Timepoints</measure>
    <time_frame>1 year</time_frame>
    <description>Distance (mm) from the left of the 100-mm VAS scale of baseline and anticipated pain recorded prior to the procedure. Distance (mm) from the left of the 100-mm VAS scale (reflecting magnitude of pain) recorded at time of speculum insertion, placement of the PCB or Sham, tenaculum placement, sounding, and 5 minutes after IUD placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intrapersonal change in pain during IUD placement</measure>
    <time_frame>1 year</time_frame>
    <description>Analysis of variation of individual pain scores for patients over several time points: baseline, speculum insertion, PCB or Sham, tenaculum placement, sounding, IUD insertion, and 5 minutes after insertion.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall pain with IUD insertion procedure</measure>
    <time_frame>1 year</time_frame>
    <description>Distance (mm) from the left of the 100-mm VAS scale (reflecting magnitude of pain) recorded 5 minutes after IUD placement.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Post-IUD Insertion Patient Questionnaire</measure>
    <time_frame>1 year</time_frame>
    <description>Patient completes 7 question multiple-choice answer questionnaire to assess patient satisfaction with pain control method.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">67</enrollment>
  <condition>Pain Due to Intrauterine Contraceptive Device</condition>
  <arm_group>
    <arm_group_label>Paracervical Block (PCB)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subject receives 2 mL 1% buffered Lidocaine anesthetic at anterior lip of cervix, where tenaculum will be placed.
Subject then receives paracervical block of 18 mL 1% buffered Lidocaine. Provider then places IUD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No Paracervical Block (Sham PCB)</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Subject receives 2 mL 1% buffered Lidocaine anesthetic at anterior lip of cervix, where tenaculum will be placed.
Subject then receives Sham paracervical block with capped needle. Provider then places IUD.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Paracervical Block (PCB)</intervention_name>
    <description>Drug: 1% Lidocaine Hydrochloride
Injection of 2 mL 1% buffered lidocaine solution at anterior lip of cervix and 18 mL 1% buffered lidocaine solution evenly distributed between 4 o'clock and 8 o'clock positions of cervix with standard 22 gauge spinal needle.
IUD placement then proceeds</description>
    <arm_group_label>Paracervical Block (PCB)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>No Paracervical Block (Sham PCB)</intervention_name>
    <description>Drug: 1% Lidocaine Hydrochloride
Injection of 2 mL 1% buffered lidocaine solution at anterior lip of cervix with standard 22 gauge spinal needle. Capped spinal needle is then held against the cervix at 4 o'clock and 8 o'clock positions of cervix, lightly so as not to cause blancing, indentation, or pain.
IUD placement then proceeds</description>
    <arm_group_label>No Paracervical Block (Sham PCB)</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Nulliparous women

          -  English or Spanish speaking

          -  Present for intrauterine device placement for contraception or menorrhagia (in the
             case of Mirena IUD insertion).

        Exclusion Criteria:

          -  Pregnancy

          -  Any diagnosed chronic pain issues (i.e. fibromyalgia, endometriosis, dysmenorrhea,
             irritable bowel syndrome, interstitial cystitis)

          -  If the patient has taken any pain medications within 6 hours of enrollment, including
             aspirin or other NSAIDs

          -  Misoprostol administration within 24 hours of enrollment

          -  History of prior IUD insertion

          -  Known contraindications to IUD
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sheila Mody, MD MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>UCSD</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>UCSD</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92103</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Planned Parenthood Mission Bay Parker Center</name>
      <address>
        <city>San Diego</city>
        <state>California</state>
        <zip>92109</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Allen RH, Bartz D, Grimes DA, Hubacher D, O'Brien P. Interventions for pain with intrauterine device insertion. Cochrane Database Syst Rev. 2009 Jul 8;(3):CD007373. doi: 10.1002/14651858.CD007373.pub2. Review. Update in: Cochrane Database Syst Rev. 2015;7:CD007373.</citation>
    <PMID>19588429</PMID>
  </reference>
  <reference>
    <citation>Cetin A, Cetin M. Effect of deep injections of local anesthetics and basal dilatation of cervix in management of pain during legal abortions. A randomized, controlled study. Contraception. 1997 Aug;56(2):85-7.</citation>
    <PMID>9315416</PMID>
  </reference>
  <reference>
    <citation>Edelman AB, Schaefer E, Olson A, Van Houten L, Bednarek P, Leclair C, Jensen JT. Effects of prophylactic misoprostol administration prior to intrauterine device insertion in nulliparous women. Contraception. 2011 Sep;84(3):234-9. doi: 10.1016/j.contraception.2011.01.016. Epub 2011 Mar 3.</citation>
    <PMID>21843686</PMID>
  </reference>
  <reference>
    <citation>Hubacher D, Reyes V, Lillo S, Zepeda A, Chen PL, Croxatto H. Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen. Am J Obstet Gynecol. 2006 Nov;195(5):1272-7.</citation>
    <PMID>17074548</PMID>
  </reference>
  <reference>
    <citation>Maguire et al. &quot;Intracervical lidocaine gel for IUD insertion: a randomized control trial.&quot; Contraception. January 2012.</citation>
  </reference>
  <reference>
    <citation>Massey SE, Varady JC, Henzl MR. Pain relief with naproxen following insertion of an intrauterine device. J Reprod Med. 1974 Dec;13(6):226-31.</citation>
    <PMID>4612152</PMID>
  </reference>
  <reference>
    <citation>Mosher WD, Jones J. Use of contraception in the United States: 1982-2008. Vital Health Stat 23. 2010 Aug;(29):1-44.</citation>
    <PMID>20939159</PMID>
  </reference>
  <reference>
    <citation>O'Connell K, Jones HE, Simon M, Saporta V, Paul M, Lichtenberg ES; National Abortion Federation Members. First-trimester surgical abortion practices: a survey of National Abortion Federation members. Contraception. 2009 May;79(5):385-92. doi: 10.1016/j.contraception.2008.11.005. Epub 2008 Dec 11.</citation>
    <PMID>19341852</PMID>
  </reference>
  <reference>
    <citation>Phair N, Jensen JT, Nichols MD. Paracervical block and elective abortion: the effect on pain of waiting between injection and procedure. Am J Obstet Gynecol. 2002 Jun;186(6):1304-7.</citation>
    <PMID>12066113</PMID>
  </reference>
  <reference>
    <citation>Rabin JM, Spitzer M, Dwyer AT, Kaiser IH. Topical anesthesia for gynecologic procedures. Obstet Gynecol. 1989 Jun;73(6):1040-4.</citation>
    <PMID>2657523</PMID>
  </reference>
  <reference>
    <citation>Renner RM, Jensen JT, Nichols MD, Edelman A. Pain control in first trimester surgical abortion. Cochrane Database Syst Rev. 2009 Apr 15;(2):CD006712. doi: 10.1002/14651858.CD006712.pub2. Review.</citation>
    <PMID>19370649</PMID>
  </reference>
  <reference>
    <citation>Roche, NE et al. &quot;The effect of peri-operative ketorolac on pain control in pregnancy termination.&quot; Contraception. Article in Press, October 2011</citation>
  </reference>
  <reference>
    <citation>Wiebe ER, Rawling M. Pain control in abortion. Int J Gynaecol Obstet. 1995 Jul;50(1):41-6.</citation>
    <PMID>7556858</PMID>
  </reference>
  <reference>
    <citation>Wiebe ER. Comparison of the efficacy of different local anesthetics and techniques of local anesthesia in therapeutic abortions. Am J Obstet Gynecol. 1992 Jul;167(1):131-4.</citation>
    <PMID>1442914</PMID>
  </reference>
  <reference>
    <citation>Zieman, Mimi et al. A Pocket Guide to Managing Contraception. The Bridging Gap Foundation. Â© 2010</citation>
  </reference>
  <reference>
    <citation>Zullo F, Pellicano M, Stigliano CM, Di Carlo C, Fabrizio A, Nappi C. Topical anesthesia for office hysteroscopy. A prospective, randomized study comparing two modalities. J Reprod Med. 1999 Oct;44(10):865-9.</citation>
    <PMID>10554747</PMID>
  </reference>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 11, 2014</study_first_submitted>
  <study_first_submitted_qc>August 14, 2014</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 18, 2014</study_first_posted>
  <last_update_submitted>March 13, 2018</last_update_submitted>
  <last_update_submitted_qc>March 13, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 15, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, San Diego</investigator_affiliation>
    <investigator_full_name>Sheila Mody</investigator_full_name>
    <investigator_title>Women's Reproductive Health Research (K12) Scholar</investigator_title>
  </responsible_party>
  <keyword>Contraception</keyword>
  <keyword>Pain</keyword>
  <keyword>Intrauterine Device</keyword>
  <keyword>Paracervical Block</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

